Annals of Epidemiology
Volume 18, Issue 9 , Pages 671-677 , September 2008

HDL-Cholesterol and Incidence of Breast Cancer in the ARIC Cohort Study

  • Anna M. Kucharska-Newton, Phd, MPH

      Affiliations

    • Departments of Epidemiology, University of North Carolina at Chapel Hill
    • Corresponding Author InformationAddress correspondence to: Anna Kucharska-Newton, 137 E Franklin St, Chapel Hill, NC 27514. Tel: (919) 966-4564.
    • ,
  • Wayne D. Rosamond, Phd

      Affiliations

    • Departments of Epidemiology, University of North Carolina at Chapel Hill
    • ,
  • Pamela J. Mink, Phd

      Affiliations

    • Emory University, Atlanta, GA
    • ,
  • Anthony J. Alberg, Phd, MPH

      Affiliations

    • Hollings Cancer Center, Medical University of South Carolina, Charleston
    • ,
  • Eyal Shahar, MD, MPH

      Affiliations

    • Division of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson
    • ,
  • Aaron R. Folsom, MD, MPH

      Affiliations

    • Division of Epidemiology and Community Health, University of Minnesota, Minneapolis

Received 23 December 2007 ,Accepted 30 June 2008.

References 

  1. Hankinson SE, Hunter D. Breast cancer. In:  Adami H-O,  Hunter D,  Trichopoulos D editor. Textbook of cancer epidemiology. New York: Oxford University Press; 2002;p. 301–339
  2. Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin. 1991;41:146–165
  3. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev. 2007;28:763–777Epub 2007 Nov 2
  4. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591
  5. Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link?. Cancer Causes Control. 1996;7:605–625
  6. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 2003;9:5699–5704
  7. Krause MP, Hallage T, Gama MPR, Sasaki JE, Miculis CP, Buzzachera CF, et al. Association between lipid profile and adiposity in women over age 60. Arquivos Brasileiros de Cardiologia. 2007;89:163–169
  8. Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. a comparison with non-cancer subjects. Int J Clin Lab Res. 2000;30:141–145
  9. Moorman P, Hulka B, Hiatt R, Krieger N, Newman B, Vogelman J, et al. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev. 1998;7:483–488
  10. Furberg A–S, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004;96:1152–1160
  11. Gaard M, Tretli S, Urdaul P. Risk of breast cancer in relation to blood lipids: a prospective study of 31, 209 Norwegian women. Cancer Causes Control. 1994;5:501–509
  12. Hoyer AP, Engholm G. Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control. 1992;3:403–408
  13. Kumar K, Sachdanandam P, Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochemistry Int. 1991;23:581–589
  14. Kokoglu E, Karaarslan I, Karaarslan HM. H.B. Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett. 1994;82:175–178
  15. Dilman VM, Berstein LM, Ostroumova MN, Tsyrlina YV, Golubev AG. Peculiarities of hyperlipidaemia in tumour patients. Br J Cancer. 1981;43:637–643
  16. Ferraroni M, Gerber M, Decarli A, Richardson S, Marubini E, De Paulet P, et al. HDL-cholesterol and breast cancer: a joint study in Northern Italy and Southern France. Int J Epidemiol. 1993;22:772–780
  17. The ARIC Investigators . The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol. 1989;129:687–702
  18. Warnick GR, Mayfield C, Benderson J, Chen JS, Albers JJ. HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymatic cholesterol assay compared with lipid research method. Am J Clin Pathol. 1982;78:718–723
  19. American Heart Association. Cholesterol Levels. [cited]; Available from: http://www.americanheart.org/presenter.jhtml?identifiers = 4500.
  20. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165–174
  21. Ferrario M, Carpenter MA, Chambless LE. Reliability of body fat distribution measurements. The ARIC Study baseline cohort results. Atherosclerosis Risk in Communities Study. Int J Obes Relat Metab Disord. 1995;19:449–457
  22. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936–942
  23. Luoto R, Sharrett AR, Schreiner P, Sorlie PD, Arnett D, Ephross S. Blood pressure and menopausal status transition: the Atherosclerosis Risk in Communities study (1987–95). J Hypertens. 2000;18:27–33
  24. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR. Serum insulin and glucose levels and breast cancer incidence: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2002;156:349–352
  25. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–137
  26. Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med. 1995;14:1707–1723
  27. Carmichael AR. Obesity and prognosis of breast cancer. Obesity Rev. 2006;7:333–340
  28. Furberg A-S, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, et al. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev. 2005;14:33–40
  29. Kawachi S-i, Takeda N, Sasaki A, Kokubo Y, Takami K, Sarui H, et al. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25:617–621
  30. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:699–704
  31. Colao A, Di Somma C, Spiezia S, Rota F, Pivonello R, Savastano S, et al. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. J Clin Endocrinol Metab. 2006;91:2191–2200
  32. Rollison DE, Newschaffer CJ, Tao Y, Pollak M, Helzlsouer KJ. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. Int J Cancer. 2006;118:1279–1284
  33. Verheus M, Peeters PHM, Kaaks R, van Noord PAH, Grobbee DE, van Gils CH. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev. 2007;16:451–457
  34. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227–236
  35. Chambless LE, McMahon RP, Brown SA, Patsch W, Heiss G, Shen Y-L. Short-term intraindividual variability in lipoprotein measurements: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992;136:1069–1081

PII: S1047-2797(08)00140-3

doi: 10.1016/j.annepidem.2008.06.006

Annals of Epidemiology
Volume 18, Issue 9 , Pages 671-677 , September 2008

Article Tools